Galmed Pharmaceuticals (EOCN) Change in Receivables (2013 - 2026)
Galmed Pharmaceuticals (EOCN) reported Change in Receivables of $211,000 for Q2 2026, compared with $14,000 a year earlier.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Change in Receivables (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Galmed Pharmaceuticals' Change in Receivables came in at -$160,000; for FY2025, it came in at -$28,000.
- By year, Change in Receivables came in at $33,000 in FY2024 (-90.4%), $345,000 in FY2023 (+15.0%), $300,000 in FY2022 and -$313,000 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Change in Receivables since Q1 2025.
- The high point for year-over-year Change in Receivables in five years was Q2 2022 (growth of 74.1%); the low point was Q2 2025 (a decline of 88.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$104,000 (Q1 2026), -$151,000 (Q4 2025) and -$116,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Galmed Pharmaceuticals | 406,071.97 | 406,071.97 | - | 211,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 211,000.00 |
| Mar 31, 2026 | -104,000.00 |
| Dec 31, 2025 | -151,000.00 |
| Sep 30, 2025 | -116,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 225,000.00 |
| Dec 31, 2024 | -21,000.00 |
| Sep 30, 2024 | -291,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Mar 31, 2024 | 226,000.00 |
| Dec 31, 2023 | 290,000.00 |
| Sep 30, 2023 | -429,000.00 |
| Jun 30, 2023 | 227,000.00 |
| Mar 31, 2023 | 257,000.00 |
| Dec 31, 2022 | 326,000.00 |
| Sep 30, 2022 | -537,000.00 |
| Jun 30, 2022 | 517,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Dec 31, 2021 | 549,000.00 |
| Sep 30, 2021 | -1.19 Mn |
API Access
Galmed Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();